Seminars in Arthritis and Rheumatism

Article	Citations
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities	127
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis	116
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review	97
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies	95
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020	70
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States	63
Antisynthetase syndrome – much more than just a myopathy	62
Axial involvement in psoriatic arthritis: An update for rheumatologists	59
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review	57
What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review	56
The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems	55
Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis	54
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO regi	50
The ASAS-OMERACT core domain set for axial spondyloarthritis	49
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data	48
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review	41
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over time	39
The economic burden of fibromyalgia: A systematic literature review	39
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study	38
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	35
The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis	35
Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study	34
Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis	34
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis	34
Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis	33

The prevalence of gout and hyperuricaemia in Australia: An updated systematic review	33
Management of calcium pyrophosphate crystal deposition disease: A systematic review	32
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience	31
Immunopathogenesis of Behçet's disease and treatment modalities	30
Gut microbiota changes in patients with spondyloarthritis: A systematic review	30
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry	29
Telemedicine in rheumatology care: A systematic review	29
The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review	29
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study	28
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial	28
Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI	28
The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2	28
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice	28
Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial	27
Towards classification criteria for early-stage knee osteoarthritis: A population-based study to enrich for progressors	27
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis	27
Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise	25
Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality	25
Rheumatoid arthritis and inflammatory bowel disease: A bidirectional two-sample Mendelian randomization study	25
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	25
Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients	25
Efficacy of home-based physical activity interventions in patients with autoimmune rheumatic diseases: A systematic review and meta-analysis	24
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)	24
Comparative effectiveness of exercise programs for psychological well-being in knee osteoarthritis: A systematic review and network meta-analysis	23
Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial	23
Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002–2016	23
Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study	23
Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica – A systematic review and meta-analysis	22
How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey	22
Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis	22
Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review	22
Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	21
Prevalence and prognostic factors for aortic dilatation in giant cell arteritis – a longitudinal study	21
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers	20
Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort	20
Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort	20
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression	20
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies	20
Shared decision making in rheumatology: A scoping review	19
Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging	19
Physical modalities for the conservative treatment of wrist and hand's tenosynovitis: A systematic review	19
The phenotype of myositis patients with anti-Ku autoantibodies	19
Understanding of cytokines and targeted therapy in macrophage activation syndrome	19
Incidence and progression of ankle osteoarthritis: The johnston county osteoarthritis project	19
Consensus-driven conceptual development of a standardized whole body-MRI scoring system for assessment of disease activity in juvenile idiopathic arthritis: MRI in JIA OMERACT working group	19
Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody	18
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial	18
Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment	18
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab	18
Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study	18

Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy	18
Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments	18
OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis	18
Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey	17
Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working group	17
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	17
Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes	17
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review	17
Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials	17
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	17
Conventional ultrasound and elastography as imaging outcome tools in autoimmune myositis: A systematic review by the OMERACT ultrasound group	17
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	17
Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review	17
Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review	16
RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs	16
Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors	16
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis	16
Systematic review of childhood-onset polyarteritis nodosa and DADA2	16
Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis: A systematic literature review focusing on validation and standardization – WSF Skin Ultrasound Group	16
Pregnancy outcomes in patients treated with belimumab: Report from real-world experience	16
The cancer risk according to three subtypes of ANCA-associated vasculitis: A propensity score-matched analysis of a nationwide study	16
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry	16
Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus	16
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study	16
Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis	16
Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study	16
Childhood Sjogren's syndrome: An Italian case series and a literature review-based cohort	15
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study	15
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	15
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients	15
AA amyloidosis revealing mevalonate kinase deficiency: A report of 20 cases including two new French cases and a comprehensive review of literature	15
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach	15
Antiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis	15
Neurological manifestations of autoinflammatory diseases in Chinese adult patients	15
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients	15
Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective: A qualitative study✰,✰✰,★,★★	15
Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review	15
Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	14
Predictors of remission in people with axial spondyloarthritis: A systematic literature review	14
Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis	14
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	14
Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus	14
Giant cell arteritis-related aortic dissection: A multicenter retrospective study	14
Drug retention rates of biological agents in adult onset Still's disease	14
Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)	14
How should we treat palindromic rheumatism? A systematic literature review	14
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases	14
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping review	14
Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis	14
Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres	14
Intestinal permeability in spondyloarthritis and rheumatoid arthritis: A systematic review of the literature	13
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit	13
How is early spondyloarthritis defined in the literature? Results from a systematic review	13
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group	13
Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study	13
Association between facet joint ankylosis and functional impairment in patients with radiographic axial spondyloarthritis	13
Unsupervised machine-learning algorithms for the identification of clinical phenotypes in the osteoarthritis initiative database	13
Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway	13
Clinical features, muscle biopsy scores, myositis specific antibody profiles and outcome in juvenile dermatomyositis	13
Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation	13
Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes	13
Fibroblasts and their responses to chronic injury in pulmonary fibrosis	13
The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis	13
Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study	13
Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease	13
Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis	13
Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis	12
Systematic review on the use of biologics in adult-onset still's disease	12
Fibromyalgia syndrome – a risk factor for poor outcomes following orthopaedic surgery: A systematic review	12
Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract	12
Health-related quality of life in early psoriatic arthritis compared with early rheumatoid arthritis and a general population	12
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus	12
Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis	12
Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting	12
Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients	12
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part I: Act	12
Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review	12
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMER	12
Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020	12
Intravenous cyclophosphamide in acute exacerbation of rheumatoid arthritis-related interstitial lung disease: A propensity-matched analysis using a nationwide inpatient database	12

A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections	12
The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis	12
Psychological stress in rheumatoid arthritis: a systematic scoping review	12
Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review	12
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	11
Diet and the risk of rheumatoid arthritis – A systematic literature review	11
Malignancy in psoriatic disease: Results from prospective longitudinal cohorts	11
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis	11
Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study	11
Prostate and pancreas involvement are linked in IgG4-related disease	11
Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment	11
Best-practice clinical management of flares in people with osteoarthritis: A scoping review of behavioral, lifestyle and adjunctive treatments	11
Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review	11
Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review	11
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	11
Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort	11
Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy	11
Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis	11
The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review	11
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study	11
Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort	11
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration	11
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	11
Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis	11
Utilizing metabolomics to identify potential biomarkers and perturbed metabolic pathways in osteoarthritis: A systematic review	11
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry	11
How can neighborhood environments facilitate management of osteoarthritis: A scoping review	10
One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days	10
Rheumatic disorders among patients with fever of unknown origin: A systematic review and meta-analysis	10
Time to transition from psoriasis to psoriatic arthritis: A population-based study	10
Association of ultrasound-confirmed axillary artery vasculitis and clinical outcomes in giant cell arteritis	10
Has the excess risk of acute myocardial infarction in rheumatoid arthritis relative to the general population declined? A population study of trends over time	10
Understanding the role and adoption of artificial intelligence techniques in rheumatology research: An in-depth review of the literature	10
International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	10
Erosive arthritis autoantibodies in systemic sclerosis	10
A multidisciplinary assessment of pain in juvenile idiopathic arthritis	10
Statins and lower mortality in rheumatic diseases: An effect of immortal time bias?	10
Predictors of Adverse outcomes in patients with systemic lupus erythematosus transitioning to adult care	10
IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement	10
A meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	10
Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study	9
Early referral of patients with suspected polymyalgia rheumatica – A systematic review	9
The mSQUASH; a valid, reliable and responsive questionnaire for daily physical activity in patients with axial spondyloarthritis	9
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review	9
Remission in psoriatic arthritis: Definition and predictors	9
Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update.	9
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	9
Autoantibodies to dense-fine-speckled 70 (DFS70) do not necessarily rule out connective tissue diseases	9
Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review	9
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group	9
Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or depression (by MDS2) on a single MDHAQ	9
All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and cl	9
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set	9
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: St	9
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis	9
In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: A 20-year follow-up in the CARRÉ cohort study	9
Anti-CD74 antibodies in spondyloarthritis: A systematic review and meta-analysis	9
Detection of multiple myositis-specific autoantibodies in unique patients with idiopathic inflammatory myopathy: A single centre-experience and literature review	9
An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis	9
Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care	9
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients	8
Risk profiling for a refractory course of giant cell arteritis: The importance of age and body weight	8
Physical frailty in patients with systemic sclerosis	8
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group	8
Metabolomics analysis reveals four biomarkers associated with the gouty arthritis progression in patients with sequential stages	8
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies	8
Using electronic visits (E-visits) to achieve goal serum urate levels in patients with gout in a rheumatology practice: A pilot study	8
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report	8
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study	8
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018	8
Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis	8
Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study	8
A comparison of 4-year total medical care costs, adverse outcomes, and opioid/prescription analgesic use for 3 knee osteoarthritis pain treatments: Intra-articular hyaluronic acid, intra-articular cor	8
Diagnostic value of different imaging features for patients with suspected gout: A network meta-analysis	8
Disentangling the relationship between depression and chronic widespread pain: A Mendelian randomisation study	8
Increased arterial stiffness and accelerated atherosclerosis in Takayasu arteritis	8
Diagnosis for early stage knee osteoarthritis: probability stratification, internal and external validation; data from the CHECK and OAI cohorts	8
Facet joint disease in patients with axial spondyloarthritis: A retrospective computed tomography study	8
Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analy	8
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	8
The pediatric glucocorticoid toxicity index	8
A systematic review and meta-analysis of questionnaires to screen for pain sensitisation and neuropathic like pain in inflammatory arthritis	8
Ultrasound evaluation of the hands and wrists in patients with systemic sclerosis: Osteophytosis is a major contributor to tender joints	8
Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis	8
Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studies	8
Rates of Pneumocystis jirovecii pneumonia and prophylaxis prescribing patterns in a large electronic health record cohort of patients with systemic lupus erythematosus	8
Pregnancy outcomes in Takayasu arteritis patients	8
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	8
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	8
Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis – data from the Danish nationwide DANBIO registry	8
Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study	8
Comprehensive disease control in systemic lupus erythematosus	8
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study	8
Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot	8
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease	8